These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37965961)

  • 21. Prediction of Serious Adverse Events of Patients with Hypertrophic Cardiomyopathy by Magnetic Resonance.
    Komuro J; Iguchi N; Utanohara Y; Takayama M; Umemura J; Tomoike H
    Int Heart J; 2021; 62(1):135-141. PubMed ID: 33518652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging in familial hypertrophic cardiomyopathy associated with abnormal thallium perfusion and cardiac enzymes.
    Nishimura T; Nagata S; Sakakibara H
    Jpn Circ J; 1988 May; 52(5):395-400. PubMed ID: 3411762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.
    Hindieh W; Chan R; Rakowski H
    Curr Cardiol Rep; 2017 Sep; 19(9):81. PubMed ID: 28752280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of hypertrophic cardiomyopathy assessed using serial cardiovascular magnetic resonance imaging.
    Romano S; Jue J; White B; Farzaneh-Far A
    Int J Cardiol; 2016 Aug; 216():156-8. PubMed ID: 27155074
    [No Abstract]   [Full Text] [Related]  

  • 25. Septal stunning by dipyridamole stress shown on quantitative gated perfusion SPECT in a child with hypertrophic cardiomyopathy.
    Paeng JC; Lee DS; Yeo JS; Noh CI; Kim YK; Chung JK; Lee MC
    Clin Nucl Med; 2002 Feb; 27(2):96-100. PubMed ID: 11786737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial for "Microvascular Dysfunction Associates With Outcomes in Hypertrophic Cardiomyopathy: Insights From the Intravoxel Incoherent Motion MRI".
    Thomaides-Brears H
    J Magn Reson Imaging; 2023 Jun; 57(6):1776-1777. PubMed ID: 36349891
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of feature tracking in cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
    Murphy T; Waterhouse D
    Int J Cardiol; 2017 Dec; 249():496. PubMed ID: 29121754
    [No Abstract]   [Full Text] [Related]  

  • 28. Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.
    Camaioni C; Knott KD; Augusto JB; Seraphim A; Rosmini S; Ricci F; Boubertakh R; Xue H; Hughes R; Captur G; Lopes LR; Brown LAE; Manisty C; Petersen SE; Plein S; Kellman P; Mohiddin SA; Moon JC
    Heart; 2020 Jun; 106(11):824-829. PubMed ID: 31822572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial perfusion abnormality in the area of ventricular septum-free wall junction and cardiovascular events in nonobstructive hypertrophic cardiomyopathy.
    Kaimoto S; Kawasaki T; Kuribayashi T; Yamano M; Miki S; Kamitani T; Matsubara H
    Int J Cardiovasc Imaging; 2012 Oct; 28(7):1829-39. PubMed ID: 22187199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re: Assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: first-pass myocardial perfusion cardiovascular magnetic resonance imaging at 1.5 T.
    Daniłowicz-Szymanowicz L; Dorniak K; Szurowska E; Dudziak M; Raczak G
    Clin Radiol; 2014 Mar; 69(3):e163-4. PubMed ID: 24290778
    [No Abstract]   [Full Text] [Related]  

  • 31. Toward Replacing Late Gadolinium Enhancement With Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy.
    Zhang Q; Burrage MK; Lukaschuk E; Shanmuganathan M; Popescu IA; Nikolaidou C; Mills R; Werys K; Hann E; Barutcu A; Polat SD; ; Salerno M; Jerosch-Herold M; Kwong RY; Watkins HC; Kramer CM; Neubauer S; Ferreira VM; Piechnik SK
    Circulation; 2021 Aug; 144(8):589-599. PubMed ID: 34229451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes.
    Das A; Kelly C; Teh I; Nguyen C; Brown LAE; Chowdhary A; Jex N; Thirunavukarasu S; Sharrack N; Gorecka M; Swoboda PP; Greenwood JP; Kellman P; Moon JC; Davies RH; Lopes LR; Joy G; Plein S; Schneider JE; Dall'Armellina E
    Eur Heart J Cardiovasc Imaging; 2022 Feb; 23(3):352-362. PubMed ID: 34694365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of left atrial strain in pediatric hypertrophic cardiomyopathy with normal maximum left atrial volume index: preliminary cardiac magnetic resonance study.
    Alis D; Asmakutlu O; Topel C; Karaarslan E
    Pediatr Radiol; 2021 Apr; 51(4):594-604. PubMed ID: 33474633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging techniques in the evaluation and management of hypertrophic cardiomyopathy.
    Kelley-Hedgepeth A; Maron MS
    Curr Heart Fail Rep; 2009 Sep; 6(3):135-41. PubMed ID: 19723454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update.
    Oliveira DC; Assunção FB; Santos AA; Nacif MS
    Arq Bras Cardiol; 2016 Aug; 107(2):163-72. PubMed ID: 27305111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Determinants of the Interventricular Septum Are Linked to Ventricular Septal Defects and Hypertrophic Cardiomyopathy.
    Yu M; Harper AR; Aguirre M; Pittman M; Tcheandjieu C; Amgalan D; Grace C; Goel A; Farrall M; Xiao K; Engreitz J; Pollard KS; Watkins H; Priest JR
    Circ Genom Precis Med; 2023 Jun; 16(3):207-215. PubMed ID: 37017090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apical hypertrophic cardiomyopathy complicated by apical aneurysm.
    Sia CH; Ho JSY; Kong WKF; Wong RCC
    J Nucl Cardiol; 2021 Apr; 28(2):756-759. PubMed ID: 32060854
    [No Abstract]   [Full Text] [Related]  

  • 38. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.
    Knaapen P; Germans T; Camici PG; Rimoldi OE; ten Cate FJ; ten Berg JM; Dijkmans PA; Boellaard R; van Dockum WG; Götte MJ; Twisk JW; van Rossum AC; Lammertsma AA; Visser FC
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H986-93. PubMed ID: 18156203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance.
    Raphael CE; Cooper R; Parker KH; Collinson J; Vassiliou V; Pennell DJ; de Silva R; Hsu LY; Greve AM; Nijjer S; Broyd C; Ali A; Keegan J; Francis DP; Davies JE; Hughes AD; Arai A; Frenneaux M; Stables RH; Di Mario C; Prasad SK
    J Am Coll Cardiol; 2016 Oct; 68(15):1651-1660. PubMed ID: 27712778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The detection of apical variant of hypertrophic cardiomyopathy in myocardial perfusion imaging.
    Akbulut A; Kalayci S; Koca G; Yigit H; Korkmaz M
    Acta Cardiol; 2019 Dec; 74(6):544-546. PubMed ID: 30650023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.